Circulation Research, Vol 64, 376-388, Copyright © 1989 by American Heart Association

ARTICLES

Heterogeneous microvascular coronary alpha-adrenergic vasoconstriction

WM Chilian, SM Layne, CL Eastham and ML Marcus
Department of Medical Physiology, Texas A&M University College of Medicine, College Station 77843.

We tested the hypothesis that humoral or neurogenic alpha-adrenergic activation in the coronary circulation would produce heterogeneous vascular reactions. To accomplish this, the epicardial coronary microcirculation was viewed through an intravital microscope using stroboscopic epi-illumination. Microvascular diameters were measured under control conditions during beta-adrenergic blockade (propranolol 1 mg/kg) and beta-adrenergic blockade with pacing; during coronary alpha- adrenergic activation in the presence of beta-adrenergic blockade with three doses of norepinephrine infusion (0.1, 0.5, and 1.0-2.0 micrograms/kg/min) or three frequencies of bilateral stellate nerve stimulation (2, 10, and 20 Hz); and during combined alpha- and beta- adrenergic blockade (phentolamine 2 mg/kg and propranolol 1 mg/kg). Diameters of both arterial and venous vessels were reduced during beta- adrenergic blockade but returned back to baseline with pacing. At the lowest level of norepinephrine infusion or frequency of bilateral stellate stimulation, microvessel constriction was not observed. At the higher doses of norepinephrine a -5.1 +/- 0.9% (1.0-2.0 micrograms/kg/min) and a -4.0 +/- 1.1% (0.5 micrograms/kg/min) decrease in diameter of arterial vessels greater than 100 microns in diameter were observed (p less than 0.05). At 10 Hz and 20 Hz of stellate stimulation, diameter decreased by -4.8 +/- 1.9% and -4.4 +/- 2.1%, respectively, in these relatively large vessels. Small coronary arterioles (less than 100 microns diameter) dilated significantly during the highest levels of nerve stimulation (9.2 +/- 2.5% increase in diameter) or infusion rate of norepinephrine (13.6 +/- 2.7% increase in diameter) (p less than 0.05). These constrictor and dilator responses were abolished following combined alpha- and beta-adrenergic blockade. Norepinephrine infusion resulted in a decrease in diameter of coronary veins and venules (7.2 +/- 1.3%) (p less than 0.05), whereas stellate stimulation did not significantly reduce venous and venular diameters. In summary, the coronary venous and venular vasculature responds to alpha-adrenergic activation from circulating norepinephrine but is not affected by stellate stimulation. In contrast, stellate stimulation and norepinephrine infusion elicit similar responses in the coronary arterial and arteriolar microvasculature. Constriction occurs in vessels greater than 100 microns in diameter, whereas dilation predominates in vessels less than 100 microns in diameter. Such heterogeneous arterial responses would undoubtedly result in a redistribution of coronary vascular resistance toward larger coronary arteries and arterioles.

This article has been cited by other articles:

				D. J. Duncker and R. J. Bache Regulation of Coronary Blood Flow During Exercise Physiol Rev, July 1, 2008; 88(3): 1009 - 1086. [Abstract] [Full Text] [PDF]

				N. Westerhof, C. Boer, R. R. Lamberts, and P. Sipkema Cross-talk between cardiac muscle and coronary vasculature. Physiol Rev, October 1, 2006; 86(4): 1263 - 1308. [Abstract] [Full Text] [PDF]

				J. D. Tune, M. W. Gorman, and E. O. Feigl Matching coronary blood flow to myocardial oxygen consumption J Appl Physiol, July 1, 2004; 97(1): 404 - 415. [Abstract] [Full Text] [PDF]

				S. Setty, W. Sun, R. Martinez, H. F. Downey, and J. D. Tune {alpha}-Adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in experimental diabetes mellitus J Appl Physiol, July 1, 2004; 97(1): 431 - 438. [Abstract] [Full Text] [PDF]

				Y. Oishi, Y. Nishimura, K.-i. Imasaka, N. Kajihara, S. Morita, M. Masuda, and H. Yasui Impairment of coronary flow reserve and left ventricular function in the brain-dead canine heart Eur. J. Cardiothorac. Surg., September 1, 2003; 24(3): 404 - 410. [Abstract] [Full Text] [PDF]

				D. Sun, A. Huang, S. Mital, M. R. Kichuk, C. C. Marboe, L. J. Addonizio, R. E. Michler, A. Koller, T. H. Hintze, and G. Kaley Norepinephrine Elicits {beta}2-Receptor-Mediated Dilation of Isolated Human Coronary Arterioles Circulation, July 30, 2002; 106(5): 550 - 555. [Abstract] [Full Text] [PDF]

				J. D. Tune, K. N. Richmond, M. W. Gorman, and E. O. Feigl Control of Coronary Blood Flow during Exercise Experimental Biology and Medicine, April 1, 2002; 227(4): 238 - 250. [Abstract] [Full Text] [PDF]

				N. Spyrou, M. A. Khan, S. D. Rosen, R. Foale, D. W. Davies, F. Sogliani, R. D. L. Stanbridge, and P. G. Camici Persistent but reversible coronary microvascular dysfunction after bypass grafting Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2634 - H2640. [Abstract] [Full Text] [PDF]

				M. W. Gorman, J. D. Tune, K. N. Richmond, and E. O. Feigl Feedforward sympathetic coronary vasodilation in exercising dogs J Appl Physiol, November 1, 2000; 89(5): 1892 - 1902. [Abstract] [Full Text] [PDF]

				Y. Nishikawa, D. W. Stepp, and W. M. Chilian Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H459 - H465. [Abstract] [Full Text] [PDF]

				G. Heusch, D. Baumgart, P. Camici, W. Chilian, L. Gregorini, O. Hess, C. Indolfi, and O. Rimoldi {alpha}-Adrenergic Coronary Vasoconstriction and Myocardial Ischemia in Humans Circulation, February 15, 2000; 101(6): 689 - 694. [Abstract] [Full Text] [PDF]

				M. D. S. Frame Conducted signals within arteriolar networks initiated by bioactive amino acids Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H1012 - H1021. [Abstract] [Full Text] [PDF]

				K. Morita, H. Mori, K. Tsujioka, A. Kimura, Y. Ogasawara, M. Goto, O. Hiramatsu, F. Kajiya, and E. O. Feigl alpha -Adrenergic vasoconstriction reduces systolic retrograde coronary blood flow Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2746 - H2755. [Abstract] [Full Text] [PDF]

				D. K. Bowles, Q. Hu, M. H. Laughlin, and M. Sturek Heterogeneity of L-type calcium current density in coronary smooth muscle Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H2083 - H2089. [Abstract] [Full Text] [PDF]

				Y. Ishibashi, D. J. Duncker, and R. J. Bache Endogenous Nitric Oxide Masks {alpha}2-Adrenergic Coronary Vasoconstriction During Exercise in the Ischemic Heart Circ. Res., February 1, 1997; 80(2): 196 - 207. [Abstract] [Full Text]

				F. W. Sellke, E. M. Boyle Jr, and E. D. Verrier Endothelial Cell Injury in Cardiovascular Surgery: The Pathophysiology of Vasomotor Dysfunction Ann. Thorac. Surg., October 1, 1996; 62(4): 1222 - 1228. [Abstract] [Full Text]